IP Verse

Shionogi patent opposition analysis

Get complete Patent Opposition Report for Shionogi

Comprehensive Analysis, Strategic Insights & Expert Evaluation – Stay Ahead in Your Patent Challenge.

Latest patents of Shionogi opposed by its competitors

Explore Shionogi's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Patent Number	Grant Date	Title	Total Oppositions
EP3045206	Feb 15, 2023	Polycyclic Carbamoylpyridone Derivative Having Hiv Integrase Inhibitory Activity	1
EP3616720	Feb 17, 2021	Pharmaceutical Composition For Cancer Treatment	20
EP2772480	Dec 9, 2020	Hiv Replication Inhibitor	1
EP3431105	Jan 1, 2020	Medicinal Composition For Treating Cancer	5
EP3284520	Jun 5, 2019	Polycyclic Carbamoylpyridone Derivative Having Hiv Integrase Inhibitory Activity	1
EP2266958	Mar 15, 2017	Antiviral Agent	1

Top competitors of Shionogi

GEVERS & ORES

GLAXOSMITHKLINE

J A KEMP